Drug · DIN 02386291
SIMVASTATIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 31, 2022; first marketed June 11, 2012.
- Drug Identification Number (DIN)
- 02386291
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Simvastatin C10AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIMVASTATIN | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2021: NOC 26752Abbreviated New Drug Submission (ANDS)
- June 8, 2012: NOC 13368Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named SIMVASTATIN
- DIN 02284723 · Marketed
- DIN 02284731 · Marketed
- DIN 02284758 · Marketed
- DIN 02284766 · Marketed
- DIN 02284774 · Marketed
- DIN 02386305 · Marketed
- DIN 02386313 · Marketed
- DIN 02386321 · Marketed
- DIN 02386348 · Marketed
- DIN 02342456 · Cancelled Pre Market
- DIN 02342464 · Cancelled Pre Market
- DIN 02342472 · Cancelled Pre Market
- DIN 02342480 · Cancelled Pre Market
- DIN 02342499 · Cancelled Pre Market
- DIN 02343142 · Cancelled Post Market
- DIN 02343150 · Cancelled Post Market
- DIN 02343169 · Cancelled Post Market
- DIN 02343177 · Cancelled Post Market
- DIN 02343185 · Cancelled Post Market
- DIN 02379503 · Cancelled Pre Market